Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

5-HT reuptake inhibitors reported by HMR

May 10, 1996

Taisho discloses new series of sigma-receptor ligands

May 10, 1996

Santen reports sigma receptor ligands as potential psychopharmacologic drugs

May 10, 1996

Naropin introduced in first markets

May 10, 1996

MK-462 deserves further study in migraine indication

May 10, 1996

Mimetix, NanoSystems to collaborate on novel naproxen formulation

May 10, 1996

TAK-218 discussed at length at Japanese meetings

May 3, 1996

Tanabe's T-477 shows neuroprotective effects

May 3, 1996

Jouveinal's neuroprotective sigma ligand JO-1994

May 3, 1996

RPR describes NMDA/glycine-site antagonists

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...